Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

593
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
593
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multiscale, Bayesian inference approach to augment mechanistic models of cell signaling with machine-learning predictions of binding affinity.

PLoS computational biology·2026
Same author

Merging metabolic modeling and imaging for screening therapeutic targets in colorectal cancer.

NPJ systems biology and applications·2025
Same author

Age-associated imbalance in immune cell regeneration varies across individuals and arises from a distinct subset of stem cells.

Cellular & molecular immunology·2024
Same author

Integrating mechanism-based T cell phenotypes into a model of tumor-immune cell interactions.

APL bioengineering·2024
Same author

Compound-SNE: Comparative alignment of t-SNEs for multiple single-cell omics data visualisation.

Bioinformatics (Oxford, England)·2024
Same author

Merging Metabolic Modeling and Imaging for Screening Therapeutic Targets in Colorectal Cancer.

bioRxiv : the preprint server for biology·2024
Same journal

Detection, communication, and individual identification with deep audio embeddings: A case study with North Atlantic right whales.

PLoS computational biology·2026
Same journal

Exploring the structural lexicon of the Proteome via Metric Geometry.

PLoS computational biology·2026
Same journal

Linking retinal sampling in neural encoding models to temporal profiles of visual processing in humans.

PLoS computational biology·2026
Same journal

CAdir: Joint clustering of cells and genes for single-cell transcriptomics with visualization-driven cluster quality assessment.

PLoS computational biology·2026
Same journal

Systematic design of auxotrophic strains and media conditions to probe metabolic functions in E. coli.

PLoS computational biology·2026
Same journal

Neuronal excitability and parameter variability in the Hodgkin-Huxley model.

PLoS computational biology·2026
See all related articles

Related Experiment Video

Updated: Aug 2, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Calibrating agent-based models to tumor images using representation learning.

Colin G Cess1, Stacey D Finley1,2,3

  • 1Alfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California, United States of America.

Plos Computational Biology
|April 21, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces a new method using neural networks to quantitatively compare agent-based models (ABMs) simulations with tumor images. This approach enables rigorous parameter estimation for complex tumor development models.

More Related Videos

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.3K
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

7.4K

Related Experiment Videos

Last Updated: Aug 2, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.3K
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

7.4K

Area of Science:

  • Computational Biology
  • Cancer Research
  • Biophysics

Background:

  • Agent-based models (ABMs) are valuable for studying tumor development and therapeutic responses, offering insights into spatiotemporal evolution.
  • Current ABM parameterization relies on disparate data sources, lacking rigorous estimation methods.
  • Existing methods struggle to quantitatively compare ABM simulations with spatial tumor image data.

Purpose of the Study:

  • To develop a novel quantitative method for comparing agent-based model (ABM) simulations with experimental tumor images.
  • To enable rigorous parameter estimation for ABMs by minimizing the distance between simulated and experimental image representations.
  • To demonstrate the application of this method for parameter fitting in distinct ABM scenarios.

Main Methods:

  • Utilized neural networks to generate low-dimensional representations (embeddings) of both tumor images and ABM simulations.
  • Defined the distance between these low-dimensional points as a quantitative measure of difference.
  • Employed standard parameter-fitting algorithms to minimize the discrepancy between simulated and experimental image embeddings.

Main Results:

  • Successfully created a quantitative framework for comparing ABM simulations and tumor images.
  • Demonstrated the method's efficacy in parameter estimation for two different ABMs.
  • Established a robust approach for enhancing the accuracy and reliability of ABM parameterization.

Conclusions:

  • The presented neural network-based approach provides a robust and quantitative method for estimating parameters in agent-based models (ABMs).
  • This technique overcomes limitations in comparing spatial data from ABM simulations and tumor images.
  • Facilitates more accurate modeling of tumor development and therapeutic responses through improved parameter fitting.